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AminopeptidaseBacillus thuringiensis Cry toxins are used in the control of insect pests. They are pore-forming toxins with a
complex mechanism that involves the sequential interaction with receptors. They are produced as protoxins,
which are activated by midgut proteases. Activated toxin binds to cadherin receptor, inducing an extra
cleavage including helix α-1, facilitating the formation of a pre-pore oligomer. The toxin oligomer binds to
secondary receptors such as aminopeptidase and inserts into lipid rafts forming pores and causing larval
death. The primary threat to efﬁcacy of Bt-toxins is the evolution of insect resistance. Engineered Cry1AMod
toxins, devoid of helix α-1, could be used for the control of resistance in lepidopterans by bypassing the
altered cadherin receptor, killing resistant insects affected in this receptor. Here we analyzed the mechanism
of action of Cry1AbMod. We found that alkaline pH and the presence of membrane lipids facilitates the
oligomerization of Cry1AbMod. In addition, tryptophan ﬂuorescence emission spectra, ELISA binding to pure
aminopeptidase receptor, calcein release assay and analysis of ionic-conductance in planar lipid bilayers,
indicated that the secondary steps in mode of action that take place after interaction with cadherin receptor
such as oligomerization, receptor binding and pore formation are similar in the Cry1AbMod and in the wild
type Cry1Ab. Finally, the membrane-associated structure of Cry1AbMod oligomer was analyzed by electron
crystallography showing that it forms a complex with a trimeric organization.© 2009 Elsevier B.V. All rights reserved.1. IntroductionBacillus thuringiensis (Bt) bacteria produce insecticidal Cry proteins
that are toxic to different insect orders, but harmless to vertebrates
and other organisms [1]. Cry toxins are produced as crystal inclusions
during the sporulation phase of the bacteria. They are pore-forming
toxins that kill susceptible insects by destroying the cells of their
midgut epithelium [1,2]. The crystal inclusions are ingested by the
larvae and solubilized in the midgut lumen due to the alkaline and
reducing environment that is present in the larval gut [1–3]. The
soluble protoxins are activated by midgut proteases producing
monomeric toxins. The activated toxins must undergo conformational
changes in order to insert into the target membrane forming ionic
pores [1,2]. In a previous study, it was demonstrated that binding ofroteins; SUV, small unilamellar
escence units; PMSF, Phenyl-
ride; HRP, horseradish perox-
wo-dimensional; OTG, octyl-β-
ll rights reserved.monomeric Cry1Ac to brush border membrane vesicles isolated from
susceptible Manduca sexta larvae induce aggregation of the toxin and
that the toxin becomes highly resistant to digestion with protease K
since only 60 amino acids in amino terminal region including helix α-
1 were cleaved [4]. Later we showed that in the case of Cry1A toxins
the interaction with the primary cadherin receptor facilitates this
additional cleavage at the N-terminal end of the toxin, which
eliminates helix α-1 of domain I [5]. This cleavage induces the
assembly of the toxin into an oligomeric pre-pore structure [5,6]. The
oligomeric toxin then binds to secondary receptors, which are glycosyl
phosphatidylinositol (GPI)-anchored proteins, such as aminopepti-
dase N (APN) or alkaline phosphatase [6–8]. Compared with toxin
monomers, the Cry toxin oligomers have increased binding afﬁnity to
the secondary receptors [6]. After binding to the secondary receptor,
the Cry toxin oligomer localizes into membrane-microdomains or
lipid rafts, where it inserts into the membrane forming pores that
cause ion leakage, cell lysis and insect death [6]. The toxin oligomer
produces stable channels in black lipid bilayers with high open
probability, in contrast to the monomeric toxin structure [9]. Point
mutations affecting oligomerization of Cry1Ab toxin were unaffected
in their binding interaction with cadherin receptor but were severely
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susceptible insect larvae [4,10], suggesting that the oligomeric toxin
pore plays a major role in the mode of action of Cry toxins in
lepidopteran larvae.
Different Cry toxins active against different insect orders showed a
similar mechanism of action, since they also form oligomeric
structures after interaction with their protein receptors [5,11–16]. In
the case of other pore-forming toxins produced by other bacteria, an
oligomeric pre-pore structure is also produced after receptor binding.
This oligomeric structure represents a toxin intermediate before
insertion into the membrane [17].
The primary threat to the long-term efﬁcacy of Bt-toxins is the
evolution of resistance by pests. Previously we showed that engineered
variants of Cry1A toxins modiﬁed to lack amino terminal end, including
helixα-1 (Cry1AbModandCry1AcMod) are able to formoligomers after
proteolysis in the absence of cadherin receptor [18]. These Cry1AMod
toxins kill resistant insects affected in cadherin gene such as Pectino-
phora gossypiella. Cry1AMod toxins also killM. sexta larvaewith reduced
cadherin expression after RNA interferenceusinga cadherin-dsRNA [18].
However, the mechanism of action of Cry1AMod toxins was not
previously analyzed. In order to propose the use of Cry1AMod toxins
in theﬁeld as an alternative to control insect resistance to Cry toxins, it is
important to demonstrate that they work with a similar mechanism as
the approved unmodiﬁed Cry1A toxins. In this regard it is important to
characterize the different steps in Cry toxin action that take place after
cadherin interaction such as binding to GPI-anchored receptors,
structural organization of oligomers and pore formation activity.
In this work we took advantage that Cry1AMod toxins oligomerize
in the absence of primary receptor interaction to study the limiting
factors affecting oligomer formation.We characterized the oligomer of
Cry1AbMod by analyzing binding to aminopeptidase N receptor and
its pore formation activity and determined some structural aspect of
the membrane-associated oligomer by tryptophan ﬂuorescence
spectroscopy and by negative staining of 2D crystals showing that
they form a complex with a trimeric organization.
2. Experimental procedures
2.1. Preparation of liposomes
Egg-yolk phosphatidylcholine (PC) at 2.6 μmol ﬁnal concentration
from a chloroform stock (Avanti Polar Lipids, Alabaster, AL), was dried
by argon ﬂow evaporation followed by overnight storage under
vacuum to remove residual chloroform. The lipids were hydrated in
2.6 ml of 150 mM KCl, and 10 mM CHES at pH 9, for 5 min followed by
vortex. To prepare small unilamellar vesicles (SUV) the lipid
suspension was subjected to sonication three times for 3 min in a
Branson-1200 bath sonicator (Danbury, CT). Liposomes were used
within 48 h upon their preparation, where they remained stable and
showed similar capacitance values. Liposomes were prepared by
keeping the total lipid concentration at 1 mM and diluted to the
required concentration just before use. Calcein containing vesicles
were prepared by sonication of the SUV liposomes in 80 mM calcein
(Molecular Probes, Eugene Oregon), three times for 3 min, dissolved
in 150 mM KCl, and 10 mM CHES at pH 9. In order to remove the non-
entrapped calcein, 650 μl of the calcein-vesicle suspension were
loaded to a gel ﬁltration Sephadex G-50 column (1×15 cm) and
eluted with the same buffer.
2.2. Puriﬁcation of Cry1AbMod and wild type Cry1Ab toxins
Bt transformants containing cry1AbMod or cry1Ab genes were
grown for 3 days at 30 °C in HCT sporulation medium supplemented
with 10 μg/ml erythromycin. The HCTmedium contained (g l−1): Bacto
Tryptone (Difco), 5; Casamino acids (Difco), 2; KH2PO4, 3.4; MgSO4.7-
H2O, 0.012; MnSO4.4H2O, 0.0003; ZnSO4.7H2O, 0.0028; the pH wasadjusted to 7.2. After sterilization Fe(SO4).7H2O, 0.02; CaCl2.2H2O 0.147
and glucose 3;were added (g l−1). The Bt strain expressing Cry1AbMod
toxin produced bipyramidal crystals similar to the wild type Cry1Ab
toxin. After sporulation, Cry1AbMod and Cry1Ab crystals were puriﬁed
by sucrose gradients [19] and protoxins were solubilized in different
pH conditions, as follows: 100 mM Tris–HCl, 0.2% β-mercaptoethanol
pH 8.5; or 100 mM CHES, 0.2% β-mercaptoethanol pH 9.0; 80 mM
NaHCO3, 20 mM Na2CO3, 0.2% β-mercaptoethanol pH 10 or pH 10.5;
100 mM piperidine 0.2% β-mercaptoethanol pH 11, 100 mM NaH2PO4,
0.2% β-mercaptoethanol pH 12 or 100 mM NaOH pH 12. Protoxin
activation was performed by 1 h incubation with trypsin at 37 °C at
different pHs as indicated in the results section, either in the presence
or in the absence of PC-SUV (5000:1 lipid:protein ratio). Proteolysis
was stopped by adding 1 mM phenylmethylsulfonyl ﬂuoride (PMSF).
For the production of wild type Cry1Ab oligomer, Cry1Ab protoxin was
activated with 0.5% M. sexta midgut juice in the presence of scFv73
antibody (1:4 protein:antibody ratio) as reported previously [5]. For
pore formation assays in black lipid bilayers the Cry1Ab or Cry1AbMod
oligomeric structures were produced in the presence of PC-SUV to
recover membrane-inserted oligomer as previously described [10]. For
ELISA binding assays or tryptophan ﬂuorescence determinations,
oligomer was prepared in the absence of PC-SUV to recover soluble
oligomer. The oligomeric structure was further puriﬁed by size-
exclusion chromatography with a Superdex 200 HR 10/30 (Amersham
Pharmacia Biotech, Uppsala, Sweden) FPLC size-exclusion column as
described [5]. The puriﬁed Cry1Ab and Cry1AbMod oligomeric
structure eluted in fractions 9–11 of the column, while monomeric
structure eluted in fractions 16–18 as previously reported [5,10].
Protein concentration was determined by the Bradford assay using
bovine serum albumin as standard and the extinction coefﬁcient
method where Em280=5700 M−1/cm−1 for Cry1Ab toxin.
2.3. Western blot
Protein samples were boiled for 5 min in Laemmli sample loading
buffer, separated in SDS-PAGE and electrotransferred onto PVDF mem-
brane (Millipore, Bedford, MA). The Cry1Ab and Cry1AbMod proteins
were detected using polyclonal anti-Cry1Ab antibody (1/15,000, for
1 h) followed by a secondary antibody coupled with horseradish
peroxidase (HRP) (Sigma, St Louis, MO) (1/5000, 1 h). This polyclonal
anti-Cry1Ab antibody was obtained as reported [20] from a New
Zealand white rabbit immunized with a Cry1Ab sample containing a
mixture of Cry1Ab monomeric and oligomeric structures obtained after
proteolytical activation in the presence of scFv73 antibody. This
antiserum readily recognized the 250-kDa oligomer and the 60 kDa
monomeric toxin, in contrast to other polyclonal antibodies obtained by
immunizing with trypsin activated Cry1Ab toxin. Blots were revealed
with luminol (ECL; Amersham Pharmacia Biotech) as described by the
manufacturers. Molecular weight markers used in all SDS-PAGE were
precision pre-stained plus standards all blue (BioRad, Hercules CA).
2.4. Tryptophan ﬂuorescence emission assays
Analysis of the Trp ﬂuorescence emission of Cry1Ab or Cry1AbMod
oligomer inserted in SUV membranes was done by adding SUV to the
protein suspension of pure soluble-oligomer in the cuvette to get a
ratio of 5000 (lipid:protein). After liposome addition,1 h of incubation
at room temperature was allowed before liposome vesicles were
recovered by ultracentrifugation at 100,000 ×g and suspended in the
same volume. The Trp emission spectra were performed as previously
described [9], three to four scans were recorded and corrected for
background and dilution. The membrane suspension was subject to
spectrum acquisition. Controls of oligomeric Cry1AbMod incubated in
the absence of membrane was performed, showing that protein
remain in solution under these experimental conditions. Control
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and subtracted from the respective protein spectra.
2.5. Puriﬁcation of aminopeptidase N (APN)
The brush border membrane APNwas puriﬁed fromM. sexta BBMV
[21] isolated from 5th instar larvae. The BBMV were solubilized 2 h at
4 °C in 20 mM Tris–HCl at pH 8.5 containing 100 mM NaCl, 5 mM
EDTA, 1 mM PMSF, and 1% CHAPS. After detergent solubilization of
BBMV the APN protein was puriﬁed using a mono-Q column as
previously reported [22]. Brieﬂy, the samples were centrifuged 1 h at
90,000 ×g and the supernatants containing the CHAPS-solubilized
proteins were concentrated by Amicon YM-50 ultraﬁltration. A 2 ml
aliquot was applied to a HR 5/10 mono-Q column equilibrated with
20 mM Tris–HCl at pH 8.5 buffer containing 2 mM MgCl2, 2 mM KCl.
The columnwas eluted with a NaCl gradient (0.5–1 M) with a ﬂow rate
of 1 ml per min for 40 min. APN activity was assayed using L-leucine-p-
nitroanilide (LpNA) as substrate [23]. Fractions containing APN activity
were pooled and concentrated by Amicon YM-50 ultraﬁltration. Quality
of APN puriﬁcation was observed in SDS-PAGE.
2.6. Toxin overlay assays
Protein blot analysis was done as described previously [20]. The
pure APN protein sample (1.3 μg) was separated by 10% SDS-PAGE and
electrotransferred to nitrocellulose membranes PVDF (Millipore,
Bedford MA). After renaturation and blocking, blots were incubated
for 2 h with 10 nM of biotinylated Cry1A toxins in washing buffer (1%
Tween 20 in PBS) at room temperature. Unbound toxin was removed
bywashing three times for 10min inwashing buffer (1ml) and bound
toxin was identiﬁed by streptavidin-peroxidase conjugate (1:5000)
for 1 h and visualized using luminol (ECL, Amersham) as described by
manufacturers.
2.7. ELISA binding assays
ELISA plates, 96-wells, were coated with 10 ng of the puriﬁed APN
in PBS buffer. After 12 h incubation at 4 °C, 200 μl PBS containing 2%
non-fat drymilk was added to eachwell and incubated for 2 h at 37 °C.
The ELISA plate was washed three times with PBS buffer, followed by
1 h incubationwith different concentrations (0.6–5 nM) of oligomeric
Cry1Ab or Cry1AbMod toxins at 37 °C. The unbound toxin was
removed by three times washing and the ELISA plate was incubated
1 h with anti-Cry1Ab antibody (1:20,000) at 37 °C. After three times
washing, the secondary antibody coupled to HRP-peroxidase
(1:10,000) was added for 1 h at 37 °C. ELISA plates were ﬁnally
washed three times. The HRP enzymatic activity was revealed with a
freshly prepared substrate (40 mg of o-phenylenediamine, 18 ml of
H2O2 in 100 ml of 100 mM NaH2PO4, at pH 5.0). The enzymatic
reactionwas stopped with 6 N HCl and the absorbance read at 490 nm
with a Pharmacia LKB Ultraspec II. Binding of monomeric Cry1Ab was
used as control in these experiments showing no binding under this
concentration range (data not shown).
2.8. Pore formation activity with calcein release assay
Calcein leakage experiments were performed as described [9].
Brieﬂy, 10 μl of calcein-loaded liposomes were added to 900 μl of
150 mM KCl, CHES 10 mM, and 2.5 mM CaCl2, at pH 9. Calcein
ﬂuorescence was excited at 490 nm and monitored at 520 nm (4 nm
slit) with an Aminco Bowman Luminescence Spectrometer (Urbana IL).
The soluble oligomeric toxin samples were added and the release of
calcein was analyzed. The released calcein induced an increase in
ﬂuorescence due to the dequenching of the dye after release into the
external medium. Maximal leakage at the end of each experiment wasassessed by adding 0.1% Triton-X-100 that clarify the SUV solution. All
ﬂuorescence experiments were performed in quadruplicate at 20 °C.
2.9. Pore forming activity in black lipid bilayers
Black lipid bilayers were made as previously reported [9,24] with
egg derived PC. Bilayer capacitance values were between 250 and
300 pF. Buffers 300 mMKCl, and 10 mM CHES, at pH 9 and 10 mMKCl,
and 10 mM CHES, at pH 9 were added to the cis and trans
compartments, respectively. Once a bilayer was formed, the activated
Cry1AbMod or Cry1Ab toxins in SUV were added to the cis
compartment; the trans compartment was held as reference ground.
All experiments were performed at room temperature. Single-channel
currents were recorded with a Dagan 3900A patch-clamp ampliﬁer
(Dagan Corp.; Minneapolis, MN). Currents were ﬁltered at 200 or
500 Hz, digitalized on-line at 1 or 2 kHz, and analyzed using a Digidata
1200 interface and Axotape and pClamp software (Axon Instruments,
Foster City, CA).
2.10. 2D crystallization of Cry1AbMod oligomers
Puriﬁed Cry1AbMod protoxin was diluted to a ﬁnal concentration
of 1.5 mg/ml in 80 mM NaHCO3, and 20 mM Na2CO3, at pH 10.5
containing trypsin at a ﬁnal dilution of 1:20 (trypsin:protoxin) and a
PC-SUV to protein mass ratio of 0.5 in a total volume of 100 μl. The
reaction was incubated 2 h at 37 °C with slow agitation. Reaction was
stopped with PMSF 0.1 mM (ﬁnal concentration) and centrifuged 1 h
at 100,000 ×g, 4 °C. The membrane pellet was suspended in 80 mM
NaHCO3, 20mMNa2CO3, and 50mMoctyl-β-D-1-thioglucopyranoside
(OTG) at pH 10.5. Finally detergent was removed by adding 0.015 g
biobeads SM2 (25–50 mesh from BioRad Hercules CA) every 4 h
during 24 h (6 additions) at 16 °C with slow agitation.
2.11. Electron microscopy
Five microliters of the protein samples was placed onto carbon-
formvar-coated copper grids G400/Cu 400 mesh square, excess liquid
was drained off with ﬁlter paper upon which the specimen was
stained with 20 μl of 2% (w/v) uranyl acetate (pH 4.25) for a few
seconds and blotted dry. Specimens were observed in a Jeol 1200 EX
transmission electronmicroscope operated at 100 kV. Electron micro-
graphs were recorded at a calibrated magniﬁcation of 37,800×.
Selected micrographs were digitized at increments so that one pixel
corresponded to 5.29 Å at the specimen level. Images were analyzed
and projectionmaps calculated using the software package CRISP [25].
2.12. Bioassays
Insect toxicity of Cry1Ab and Cry1AbMod toxins was assayed with
ﬁrst instar M. sexta larvae by the diet-surface contamination
procedure. The protoxins Cry1Ab and Cry1AbMod were solubilized
at pH 10.5. A constant volume of the sample dilutions in water (35 μl)
was applied onto the diet surface contained in 24-well polystyrene
plates (Cell Wells, Corning Glass Works, Corning NY). One ﬁrst instar
larva was added per well and one 24-well plate was used per toxin
concentration. The plates were incubated at 28 °C, 65±5% of relative
humidity, and a light:dark photoperiod of 16:8 h. Mortality ofM. sexta
larvae was recorded after seven days. Aedes aegypti and Anopheles
albimanusmosquitoes were reared at 28 °C, 87% RH and 12:12 h light:
dark photoperiod. Twenty early fourth-instar larvae were placed in
100 ml of dechlorinated water. Spore–crystal complex of Cry1Ab or
Cry1AbMod were used in the mosquito-bioassays (three repetitions).
A negative control of dechlorinated water was included. A. aegypti and
A. albimanus larvae were incubated at 28 °C and mortality was
examined after 24 h. A positive control of Bt subsp. israelensis was
included in the bioassay. The mean lethal concentration (LC50) was
Fig. 2. Analysis of APN puriﬁcation from Manduca sexta BBMV. Lane 1, SDS-PAGE 10%
polyacrylamide electrophoresis of puriﬁed APN sample stained with coomasie blue
staining. Lane 2, binding of biotinylated Cry1Ab to APN sample in toxin overlay assay
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four independent assays (Polo-PC LeOra Software).
3. Results
3.1. Effect of pH on the oligomerization of Cry1AbMod toxin
We have previously shown that Cry1AbMod protoxin forms
oligomers when activated with trypsin in the absence of cadherin
receptor in contrast with Cry1Ab toxin [18]. Since pH is an important
determinant of protein ﬂexibility, we analyzed the effect of pH in toxin
oligomerization. In the case of the wild type Cry1Ab toxin, it was
previously shown that alkaline pH increased the ﬂexibility of
monomeric toxin [9]. The pH of the midgut lumen of lepidopteran
insectM. sextawas measured and shown to be alkaline pH 10. In order
to analyze the effect of pH on the formation of oligomeric structure,
the Cry1AbMod toxin was proteolytically activated with trypsin at
different pH. Oligomerization was analyzed as the formation of SDS-
resistant aggregates of 250 kDa in SDS-PAGE as previously reported
for different Cry toxins [5,11–16]. Several bacterial pore-forming
toxins such as PA-anthrax toxin, aerolysin and α-toxin also formed
oligomeric structures that could be observed in SDS-PAGE [17]. Fig. 1Fig. 1. Activation of Cry1AbMod and Cry1Ab with trypsin at different pH. The presence
of 250 kDa oligomeric structurewas evaluated by western blot assay using speciﬁc anti-
Cry1Ab polyclonal antibody. Activation pH is indicated on the top of each lane. Five
micrograms of protein was loaded in each lane (SDS-PAGE 8% poyacrylamide gels).
Panel A activation in solution. Panel B activation in the presence of PC-SUV liposomes at
a 5000:1 lipid:protein ratio. Numbers within the images represent the percentage of
signal of oligomeric vs. monomeric bands determined by scanning optical density of
bands in the blots.
revealed after incubation with streptavidin-peroxidase conjugate and visualized with
luminol as described in Experimental procedures.shows that Cry1AbMod toxin could form oligomeric structures after
trypsin activation in the absence cadherin receptors. This ﬁgure also
shows that the oligomerization of this protein increased when
incubation was done at high pH in contrast with incubations at pH
8.5. As expected, the wild type Cry1Ab toxin did not form oligomeric
structures after activationwith trypsin (Fig. 1A). In addition, we found
that the presence of PC-SUV during toxin activation provide a
membrane substrate in which the toxin could bind and form pores,
facilitating the production of the oligomeric structure (Fig. 1B). The
relative proportion the oligomeric and the monomeric structures of
Cry1AbMod after activation in the presence or absence of PC-SUV was
determined by scanning optical density of the bands in the blots,
showing that in the presence of PC-SUV the ratio of oligomeric/
monomeric structure was enhanced.3.2. Fluorescence Trp emission of Cry1AbMod oligomer
In order to analyze if the Cry1AbMod oligomer is structurally
similar to the oligomeric structure of the wild type Cry1Ab, the Trp
ﬂuorescence emission of this protein was analyzed in the soluble pre-
pore and in the membrane-associated state. The emission maximum
of the oligomeric structure of Cry1AbMod in solution was at 333 nm,
which corresponds exactly with the previously reported emission
maximum for the oligomer of Cry1Ab toxin [9].
The emission spectrum of Cry1AbMod membrane-associated
oligomer, was performed after incubation of the oligomeric structure
with PC-SUV using a lipid:protein ratio of 5000 since it was pre-
viously reported that the threshold limit for partition of Cry1Ab
oligomer into the SUV was a lipid:protein ratio of 3000 [9]. The
membrane fraction was separated by ultracentrifugation and
ﬂuorescence spectra were recorded in the pellet fraction. The
oligomeric Cry1AbMod has a blue shift of 5 nm in the emission
spectrum λmax from 333 nm in solution to 328 nm when inserted
into SUV liposomes, indicating a more hydrophobic environment for
some of the Trp residues. A similar shift in the maximal emission
spectrum of the wild type Cry1Ab membrane-inserted oligomer was
also observed. These data indicate that structure of the oligomer
formed by the Cry1AbMod toxin is similar to that of the wild type
Cry1Ab toxin.
Fig. 3. ELISA binding of Cry1Ab and Cry1AbMod oligomers to puriﬁed APN from Man-
duca sexta midgut microvilli. ELISA plates were coated with puriﬁed APN and then
incubated with different concentrations of Cry1Ab or Cry1AbMod oligomers (0.6–
5 nM). Bound Cry1Ab oligomer (black squares ■) or Cry1AbMod oligomer (white
squares □) were detected with anti-Cry1Ab antibody followed by a secondary goat-
anti-rabbit-HRP antibody.
Fig. 5. Ionic currents induced by oligomeric structure of Cry1AbMod in planar lipid
bilayers. Panel A, Representative ionic channel records of most common transitions
induced by Cry1AbMod toxins in lipid bilayers. The observed responses showed stable
channels with high open probability. Records were obtained in 300:10 mM KCl (cis:
trans), 10 mM CHES pH 9. Panel B, Current/voltage (I/V) relationship of currents
induced by the Cry1AbMod toxin.
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APN receptor
We have previously reported that Cry1Ab oligomer binds a protein
extract enriched in M. sexta APN activity with 0.7 nM apparent
binding afﬁnity (KD). In contrast, the monomeric toxin binds this
protein extract with 160 nM KD [6]. We puriﬁed APN protein from 5th
instar larvae as described in experimental procedures and the
fractions with APN activity were analyzed by SDS-PAGE 10%
polyacrylamide revealing a single band of 120 kDa (Fig. 2, lane 1).
This sample lacks alkaline phosphatase activity (data not shown). The
quality of the puriﬁed APN sample was also tested by analyzing the
binding of biotinylated Cry1Ab toxin, in toxin overlay assays, showing
that Cry1Ab only binds to the 120-kDa band indicating that no other
Cry1Ab-binding proteins were present in the APN sample (Fig. 2, lane
2). To study the interaction of Cry1Ab and Cry1AbMod oligomeric
structures with the puriﬁed APN sample, the binding of different
concentrations of these proteins was analyzed by ELISA assays. Fig. 3Fig. 4. Pore formation activity of Cry1Ab or Cry1AbMod analyzed by calcein release assays. Pa
at pH 10.5. 50 nM of Cry1Ab or Cry1AbMod protoxins (dotted bars) or trypsin activated pro
experiment was assessed with 0.1% Triton-X-100. Panel B, Pore formation activity of the Cry1
the integrity of lipid membrane vesicles was determined by the calcein release assay perform
ﬁgure. Control is same amount of buffer. Arrow indicates toxin addition. Panel C, Dose–respo
calcein release assay at pH 9.0.shows that both, Cry1Ab or Cry1AbMod oligomeric structures bound
to theM. sexta APN with a similar high afﬁnity indicating also that the
Cry1AbMod oligomer is structurally similar to that of Cry1Ab.nel A, analysis of calcein released by trypsin activated samples of Cry1Ab or Cry1AbMod
teins (black bars) were used in these experiments. Maximal leakage at the end of each
AbMod as a function of the pH used during toxin activation. The effect of Cry1AbMod on
ed at pH 9.0 using toxin samples activated at different pH with trypsin as stated in the
nse curve of Cry1AbMod toxin activated at pH 10.5 with trypsin and analyzed using the
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To further analyze the functionality of Cry1AbMod oligomer, we
analyzed its pore formation activity using two different procedures,
the calcein release assay and measurement of ionic-conductance in
planar lipid bilayers.We ﬁrst analyzed the release of entrapped calcein
from liposomes due to the formation of pores by toxin oligomers. The
dequenching of the calcein ﬂuorescence was monitored continuously
as an increase in the ﬂuorescence intensity. Data are expressed as
percentage of the maximal ﬂuorescence release, obtained with the
positive control 1% Triton-X-100. The analysis of calcein release
induced by trypsin activated-Cry1AbMod is shown in Fig. 4.
Cry1AbMod trypsin activated toxin induced a signiﬁcant release of
calcein from loaded liposomes. In contrast the Cry1AbMod protoxin,
Cry1Ab protoxin and the Cry1Ab trypsin activated protein showed a
minor response (Fig. 4A). We then assayed the pore formation activity
of the Cry1AbMod samples activated with trypsin at different pH, in
order to analyze if oligomer formation correlated with pore formation
activity. Fig. 4B shows that Cry1AbMod toxin showed a more efﬁcient
response after activation at pH 12 in contrast to pH 8.5, correlating
with the increased production of oligomeric structure in this
condition. Finally, the dose–response curve of Cry1AbMod toxin thatFig. 6. Analysis of the structure of the lipid associated Cry1AbMod oligomer. Panel A, Electro
areamarked by a dashed circlewas used for calculating the Fourier projectionmap shown in p
cell.was activated at pH 10.5 is presented in Fig. 4C. A direct correlation of
calcein released from the SUV with the concentration of Cry1AbMod
toxin showed that the half maximal effective concentration at which
50% of calcein has been released (EC50) was 54.2 nM.
In addition, the induced ionic channel activity Cry1AbMod was
also examined in synthetic planar lipid bilayers. We recorded the
current amplitude using protein samples that were activated with
trypsin at pH 10.5 in the presence of SUV liposomes. Control sample
containing only SUV gave a no-response. These experiments were
performed in a KCl gradient 300/10 mM in the cis/trans compart-
ments to facilitate liposome fusion in the bilayer. The conductance of
Cry1AbMod was 6.0 pS similar to the wild type toxin that showed a
value of 7.5 pS [9]. The ionic currents in these experiments revealed
that oligomeric structure of Cry1AbMod produced stable channels
with high open probability (Fig. 5) that are similar to the previously
described pores induced by Cry1Ab wild type oligomer [9].
3.5. Lipid associated structure of Cry1AbMod oligomer
Since the results reported so far indicated that the oligomeric
structure of Cry1AbMod analyzed by Trp emission, pore formation and
receptor interaction resembles that of the wild type Cry1Ab oligomer,n micrograph of negatively stained 2D crystals. The scale corresponds to 50 nm and the
anel B (half tone) and panel C (contour lines). There is one trimer per a=b=107 Å unit
Table 1
Toxicity of wild type Cry1Ab and modiﬁed Cry1AbMod toxins against Manduca sexta,
Anopheles albimanus and Aedes aegypti larvae.
δ-endotoxin Manduca sexta ng/cm2
(95% conﬁdence limits)
Anopheles albimanus
μg/ml
Aedes aegypti
μg/ml
Cry1Ab 1.9 (0.99–2.47) N10 N10
Cry1AbMod 3.2 (1.4–5.4) N10 N10
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associated structure of the oligomer by electron crystallography. We
took advantage that Cry1AbMod toxin forms oligomeric structure in
the absence of any other protein as cadherin receptor that could
potentially interfere with the formation of ordered arrays. We induced
the formation of two-dimensional (2D) crystal of Cry1AbMod that
allow us to determine the structural organization of the membrane-
inserted pore. The 2D crystals were obtained after toxin insertion into
PC membrane as reported in experimental procedures section. This
method involves removing the detergent from the micellar solution
containing the protein and the lipids. We used hydrophobic adsorp-
tion of detergent onto polystyrene Bio-beads SM2 as previously
described [27]. Ordered arrays of the membrane-associated toxin
were observed with a=b=107 Å and γ=120° calculated in p3, and
the calculated projection map displayed an organization resembling a
trimeric propeller (Fig. 6).
3.6. Toxicity of Cry1AbMod toxin
The Cry1AbMod toxin was tested in bioassays against the
lepidopteran larvae, M. sexta. We also analyzed toxicity against two
different dipteran larvae, A. aegypti and A. albimanus. The speciﬁcity of
Cry1AbMod did not change since no toxicity was observed against A.
aegypti or A. albimanus mosquito larvae and similar toxicity of the
Cry1Ab was observed against M. sexta larvae (Table 1).
4. Discussion
The Cry1AbMod is essentially identical to its parental Cry1Ab
protoxin with the exception that 56 amino acids from the amino
terminal end were removed by genetic engineering [18]. The most
important characteristic of these Cry1AMod toxins is that they are
able to kill resistant insects that are affected in cadherin gene,
representing a viable alternative in the control of insects that become
resistant towild type Cry1A toxins. Although it was demonstrated that
Cry1AMod toxins formed oligomeric structures in the absence of
cadherin receptor, the other steps in the toxin mode of action such as
binding interaction with the APN receptor and its pore formation
activity were not analyzed before. In this work we analyzed these
parameters and also analyzed the structural conformation of the
membrane-inserted oligomer.
4.1. Analysis of oligomerization of Cry1AbMod toxin
Our results show that the oligomerization process is facilitated by
alkaline pH and in the presence of membrane lipids. These data are
interesting since the in vivo pH of the midgut lumen of Lepidopteran
insects is also highly alkaline (up to pH 11) [3], suggesting that pH
may play an important role during toxin activation and oligomeriza-
tion in vivo.
It was previously demonstrated that alkaline pH increase the
ﬂexibility of the monomeric and oligomeric form of Cry1Ab toxin
[28,29], by showing that Cry1Ab toxin was highly susceptible to
denaturationwith low urea concentrations only at alkaline pH [28,29].
These data suggest that alkaline pH in themidgut lumen of susceptible
larvae may facilitate a looser conformation of the Cry1Ab toxin that is
important to trigger oligomerization and therefore for active channelformation. Interestingly, in the case of colepteran speciﬁc Cry3A toxin,
the acidic pH that induced unfolding of this toxin correlated with the
acidic pH that is present in the midgut lumen of susceptible
Coleopteran larvae [30]. Similarly, in the case of other pore-forming
toxins active against mammalian cells, it was shown that they must
partially unfold to facilitate pre-pore formation [17,31–33]. These
toxins unfold under acidic pH conditions, correlating with the acidic
pH that these toxins encounter upon cell internalization in acidic
membrane compartments [17,31–33].
Other Cry toxins besides Cry1A toxins form oligomeric structures
when they were activated in the presence of their natural receptor.
This is the case of Cry1Aa, Cry1Ab, Cry1Ca, Cry1 Da, Cry1Ea and Cry1Fa
toxins active against M. sexta, that form oligomers after activation in
the presence of M. sexta BBMV [4,5,7,11–13]. An oligomeric structure
of Cry1C was observed when it was activated in the presence of Spo-
doptera exigua BBMV [13] and oligomers of Cry1Aa were observed
when activated in the presence of Bombyx mori BBMV [34]. The
colepteran speciﬁc Cry3 toxins, formed oligomeric structures after
activation in the presence of the susceptible insect Leptinotarsa
decemlineata BBMV [14]. Finally, in the case of the dipteran speciﬁc
toxins, the Cry11Aa form oligomers of 250 kDa after activation in the
presence of the mosquito A. aegypti BBMV [15]. The Cry4Ba also
formed oligomeric structures after activation [16]. In all cases the
presence of oligomers correlated with higher K+ permeability, in
contrast with monomeric toxins [5,9,11,14,15]. These data support the
hypothesis that the formation of a pre-pore oligomer is a conserved
mechanism on different members of the Cry family and that is an
intermediate responsible for pore formation.
4.2. Characterization of oligomeric structure of Cry1AbMod
In this work we show that the Cry1AbMod oligomer has a similar
conformation as the wild type Cry1Ab oligomer structure both in
solution and in the membrane-inserted state as judged by
tryptophan ﬂuorescence emission analysis. We are also reporting
that Cry1AbMod oligomer binds APN with high afﬁnity as the wild
type Cry1Ab oligomer and that they show similar pore formation
activity. The Cry1AbMod toxin produces stable channels in black
lipid bilayers with high open probability and similar conductance to
the previously reported pores of Cry1Ab toxin [9]. These data
conﬁrm that Cry1AbMod toxin shares a similar mode of action as
Cry1Ab toxin.
We took advantage that Cry1AMod toxins are more efﬁcient to
form oligomeric structure in vitro in absence of receptor protein to
improve oligomer formation and to study its conformation by electron
crystallography. The composition of the Cry1Ab oligomer was
previously suggested to be comprised of four monomers based on
molecular weight of the oligomeric structure as determined by SDS-
PAGE [5]. However, 2D crystallographic analysis performed here, show
a trimeric organization of the membrane-associated structure of the
Cry1AbMod. These results are in agreement with the previously
described organization of the membrane-associated Cry4Ba [35],
where calculated projection structures from 2D crystal patches
analyzed by electron crystallography at 17 Å resolution showed also
a trimeric organization [35]. The projection map presented herein
highlights propeller-like densities similar to the ones reported by
Ounjai et al. [35] albeit with distal domains that are somewhat
narrower. This overall architecture and assembly pattern is in contrast
to the structure of Cry1Aa trypsin activated-toxin analyzed by Atomic
Force Microscopy (AFM), for which a structure composed of four
subunits surrounding a 1.5 nm diameter central depression was
reported [36]. However, it is important to mention that the AFM
studies were performed with Cry1Aa inserted into monolayer
membranes, which may cause some artifacts.
Recently, based on sensitivity of membrane-inserted toxin to
protease and determination of ﬂuorescence quenchingmeasurements
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toxin, it was suggested that the three domains of this protein insert
into the membrane [37]. However, other studies suggest that only
domain I may be inserted into the membrane and that domain III is
exposed to the solvent [28,38]. Speciﬁcally, quenching studies of Trp
ﬂuorescence of Cry1Ac with the soluble quencher KI clearly
demonstrate that at least Trp545 located in domain III is exposed to
the solvent when the oligomeric Cry1Ac toxin is inserted into the
membrane [38]. Evidently more studies are necessary and the
description of the structure of the membrane-inserted pore of Cry1A
toxins is necessary to determine the exact architecture of the pore and
deﬁne the regions of the toxin that participate in membrane insertion.
4.3. Insecticidal activity of Cry1AbMod
The Cry1AbMod toxin was shown to kill a P. gossypiella resistant
population whose resistance was linked to deletions in the cadherin
gene [18,39]. We show here that Cry1AbMod is not toxic to mosquito
larvae and retain similar toxicity against the susceptible M. sexta
larvae, indicating that the spectrum of action of Cry1AbMod toxins
was not drastically modiﬁed. The toxicity of Cry1AbMod against M.
sexta was slightly lower but since 95% conﬁdential limits are
overlapping, we may conclude that both proteins showed similar
insecticidal activity. These results suggest that although the modiﬁed
Cry1AbMod do not require interaction with the primary cadherin
receptor, they did not become unspeciﬁc. It is possible that their
speciﬁc interaction with the secondary GPI-anchored receptors such
as APN play an important role in Cry1A toxins toxicity (Table 1).
4.4. Concluding remarks
The Cry1AMod toxins are toxic against insect pests that developed
resistance to natural Cry1A toxins. In order to develop transgenic
crops producing Cry1AMod toxins to counter insect resistance, it is
important to show that the mechanism of action of Cry1AMod toxins
is similar to the approved unmodiﬁed Cry1A toxins, that are currently
used in different transgenic crops. Here we show that secondary steps
in mode of action of Cry1Ab toxin, that take place after interaction
with cadherin receptor, such as binding to aminopeptidase, oligomer-
ization and pore formation of both proteins, Cry1A and Cry1AMod,
are similar in Cry1AbMod toxin. This knowledge will be important for
the future application of Cry1AMod toxins to counteract resistance to
Bt-crops that may assure a long-term use of this environmental
friendly technology, avoiding the use of harmful chemical pesticides
in agriculture.
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